CY1121668T1 - Συνθεσεις οι οποιες περιλαμβανουν peg και ασκορβικο - Google Patents

Συνθεσεις οι οποιες περιλαμβανουν peg και ασκορβικο

Info

Publication number
CY1121668T1
CY1121668T1 CY20191100580T CY191100580T CY1121668T1 CY 1121668 T1 CY1121668 T1 CY 1121668T1 CY 20191100580 T CY20191100580 T CY 20191100580T CY 191100580 T CY191100580 T CY 191100580T CY 1121668 T1 CY1121668 T1 CY 1121668T1
Authority
CY
Cyprus
Prior art keywords
compositions
ascorbate
include peg
solutions
per liter
Prior art date
Application number
CY20191100580T
Other languages
English (en)
Inventor
Lucy CLAYTON
Alasdair Cockett
Mark CHRISTODOULOU
Ian Davidson
Lynn FARRAG
Marc Halphen
Leighton Jones
Vanik Petrossian
Peter Stein
David Tisi
Alex Ungar
Jeffrey WORTHINGTON
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49165735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1121668(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of CY1121668T1 publication Critical patent/CY1121668T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Η εφεύρεση παρέχει ένα διάλυμα καθαρισμού του παχέος εντέρου το οποίο περιλαμβάνει: a) 300 έως 800 mmol ανά λίτρο ασκορβικού ανιόντος παρεχόμενου από ένα μείγμα: (i) ασκορβικού οξέος και (ii) ένα ή περισσότερα άλατα ασκορβικού οξέος με τα συστατικά (i) και (ii) να υπάρχουν σε μια γραμμομοριακή αναλογία από 1:4,5 έως 1:7,0· και b) 10 έως 200 g ανά λίτρο πολυαιθυλενογλυκόλης. Η εφεύρεση παρέχει επίσης μεθόδους και κυτία που συνδέονται με, ή χρησιμοποιούν τα διαλύματα και τις συνθέσεις για την παρασκευή των διαλυμάτων.
CY20191100580T 2012-09-11 2019-05-31 Συνθεσεις οι οποιες περιλαμβανουν peg και ασκορβικο CY1121668T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261699488P 2012-09-11 2012-09-11
US201361787366P 2013-03-15 2013-03-15
PCT/EP2013/068738 WO2014040994A1 (en) 2012-09-11 2013-09-10 Compositions comprising peg and ascorbate

Publications (1)

Publication Number Publication Date
CY1121668T1 true CY1121668T1 (el) 2020-07-31

Family

ID=49165735

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191100580T CY1121668T1 (el) 2012-09-11 2019-05-31 Συνθεσεις οι οποιες περιλαμβανουν peg και ασκορβικο

Country Status (33)

Country Link
US (9) US20140186470A1 (el)
EP (2) EP3473248B1 (el)
JP (3) JP6655391B2 (el)
KR (5) KR20210063445A (el)
CN (2) CN105007915B (el)
AR (1) AR092500A1 (el)
AU (2) AU2013314442C1 (el)
BR (1) BR112015005270B1 (el)
CA (2) CA2884472C (el)
CY (1) CY1121668T1 (el)
DK (2) DK3473248T3 (el)
EA (1) EA028866B1 (el)
ES (3) ES2728459T3 (el)
HK (1) HK1206604A1 (el)
HR (1) HRP20191007T1 (el)
HU (1) HUE043605T2 (el)
IL (2) IL237377B (el)
IN (1) IN2015DN01704A (el)
LT (1) LT2895163T (el)
ME (1) ME03413B (el)
MX (2) MX359318B (el)
MY (2) MY193378A (el)
NL (1) NL2011424C2 (el)
NZ (2) NZ743984A (el)
PL (2) PL3473248T3 (el)
PT (2) PT3473248T (el)
RS (1) RS58979B1 (el)
SG (4) SG10201702005VA (el)
SI (1) SI2895163T1 (el)
TW (2) TWI687238B (el)
UA (1) UA116546C2 (el)
WO (1) WO2014040994A1 (el)
ZA (2) ZA201501415B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) * 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
KR20210063445A (ko) * 2012-09-11 2021-06-01 노어긴 비.브이. Peg 및 아스코르베이트를 포함하는 조성물
PT2968174T (pt) 2013-03-15 2020-01-15 Braintree Laboratories Inc Comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e seus métodos de utilização
SG11201606834QA (en) * 2014-03-10 2016-09-29 Norgine Bv Method of cleansing the colon
WO2017120385A1 (en) * 2016-01-06 2017-07-13 California Institute Of Technology Polymeric compositions and related systems and methods for regulating biological hydrogels
FR3049464B1 (fr) * 2016-03-29 2021-08-06 Marc Girard Preparations coliques
KR20190093489A (ko) 2018-02-01 2019-08-09 주식회사태준제약 장세척 조성물
WO2019151829A1 (ko) * 2018-02-01 2019-08-08 주식회사태준제약 장세척 조성물
JP7011629B2 (ja) * 2019-07-11 2022-01-26 ノージン ビーブイ 結腸を洗浄する方法
CN110339158B (zh) * 2019-08-21 2020-11-13 扬子江药业集团上海海尼药业有限公司 一种硫酸钠钾镁口服溶液及其制备方法
US20210196748A1 (en) * 2019-12-30 2021-07-01 Robert Olson Composition and therapy for treatment of gag reflexes
KR20220033790A (ko) * 2020-09-10 2022-03-17 강윤식 장 정결용 조성물
WO2022182173A1 (ko) * 2021-02-26 2022-09-01 주식회사태준제약 장세척을 위한 조성물

Family Cites Families (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2187467A (en) 1939-02-11 1940-01-16 Lilly Co Eli Cevitamate solution
US2427692A (en) 1940-07-29 1947-09-23 Frances R Ruskin Therapeutic metal cevitamate compositions
US2481353A (en) 1946-10-25 1949-09-06 Schnabel Lewis Wilson Method of manufacturing vitamin concentrates
US2694719A (en) 1949-02-12 1954-11-16 Opplt Jan Method of stabilizing ascorbic acid with alkali-thiosulfate-carbamide-complexes
US3211614A (en) 1963-07-10 1965-10-12 Pharmacia Ab Enema-type laxative composition
EP0231356A1 (en) 1985-08-01 1987-08-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation
JPS6295194A (ja) 1985-10-18 1987-05-01 Sekisui Chem Co Ltd ミネラルウオ−タ−製造剤
JPH0540310Y2 (el) 1985-12-06 1993-10-13
JP2557111Y2 (ja) 1986-07-11 1997-12-08 富士電機株式会社 自動販売機の商品収納棚における商品残量表示装置
DE3807712A1 (de) 1987-07-25 1989-02-02 Nordend Apotheke Angela Hein Arzneimittel-trockenpraeparat zur bereitung einer laxativ wirkenden trinkloesung sowie ein verfahren zur herstellung dieses praeparates
JPH01125319A (ja) 1987-11-11 1989-05-17 Morishita Seiyaku Kk 全腸管洗浄液用投与組成物
JP2596764B2 (ja) 1987-11-18 1997-04-02 ルセル森下株式会社 腸管洗浄液剤
US5274001A (en) * 1987-12-24 1993-12-28 Borody Thomas J Orthostatic lavage solutions
JP2630423B2 (ja) 1988-05-06 1997-07-16 富山化学工業株式会社 低ナトリウム塩味料
JPH0816061B2 (ja) 1988-07-13 1996-02-21 森下ルセル株式会社 腸管洗浄液用組成物と腸管洗浄液
SE465669B (sv) 1988-07-15 1991-10-14 Hanson & Moehring Ab Salt foer livsmedelsaendamaal samt foerfarande foer dess framstaellning
JPH0263042A (ja) 1988-08-30 1990-03-02 Fuji Photo Film Co Ltd 放射線画像情報記録読取装置
JP2936168B2 (ja) 1988-12-27 1999-08-23 東ソー株式会社 ポリオレフィンの製造法
US5540945A (en) 1989-05-11 1996-07-30 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
JP2557111B2 (ja) 1989-11-27 1996-11-27 フジックス 株式会社 高濃度のマグネシウム溶液の製造方法及びそれによって得られたマグネシウム溶液並びにその用途
FR2662442A1 (fr) 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
JPH04112830A (ja) 1990-08-31 1992-04-14 Morishita Pharmaceut Co Ltd 腸管洗浄液用組成物の製造法
JP3457012B2 (ja) 1992-01-14 2003-10-14 富士化学工業株式会社 非晶質クエン酸マグネシウム顆粒物質及びその製造法
CN1045383C (zh) 1993-04-07 1999-10-06 王慧康 用于治疗老年性白内障的药物组合物
JPH06295194A (ja) 1993-04-08 1994-10-21 Matsushita Electric Ind Co Ltd 信号比較装置
JP3850891B2 (ja) 1994-03-01 2006-11-29 ゼリア新薬工業株式会社 緩下効果を有する組成物
US5411745A (en) 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
JP3439559B2 (ja) 1995-02-01 2003-08-25 三栄源エフ・エフ・アイ株式会社 食品の風味向上法
AUPN634595A0 (en) 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
CN1150021A (zh) 1996-01-11 1997-05-21 李智军 清肠剂
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
JP4092748B2 (ja) 1997-09-05 2008-05-28 ニプロ株式会社 腸管洗浄液
JPH11228423A (ja) 1998-02-17 1999-08-24 Ohara Yakuhin Kogyo Kk 腸管洗浄液用組成物
CN1093259C (zh) 1998-04-29 2002-10-23 宝山钢铁股份有限公司 乳化液皂化值和杂油含量的测定方法
CZ9900555A3 (cs) 1999-02-19 2000-10-11 Radomír Ing. Špetík Způsob mimotělní identifikace maligního a jiného onemocnění lidí a směs látek jako stimulantu krve
US6444198B1 (en) 1999-02-22 2002-09-03 Smithkline Beecham Corporation Effervescent laxatives
AUPQ847000A0 (en) 2000-06-29 2000-07-27 Adventures Plus Pty Ltd Nutrient beverage
SE518524C2 (sv) 2000-12-21 2002-10-22 Vaederstad Verken Ab Regleranordning för en jordbruksmaskin
JP2002207002A (ja) 2001-01-10 2002-07-26 Hitachi Eng Co Ltd 大気環境シミュレーションシステム
CN1143678C (zh) 2001-02-23 2004-03-31 东北制药总厂 Vc－磷酸酯镁在制备治疗便秘药物中的应用
JP2002265372A (ja) 2001-03-07 2002-09-18 Shimizu Pharmaceutical Co Ltd 腸管洗浄製剤
RU2178292C1 (ru) 2001-04-13 2002-01-20 Государственный научный центр колопроктологии Министерства здравоохранения и медицинской промышленности РФ Средство для общего промывания желудочно-кишечного тракта
JP5041642B2 (ja) 2001-08-30 2012-10-03 日本製薬株式会社 経口腸管洗浄液用組成物及び経口腸管洗浄液用充填製剤
US6592901B2 (en) 2001-10-15 2003-07-15 Hercules Incorporated Highly compressible ethylcellulose for tableting
AU2002335900A1 (en) 2001-10-29 2003-05-12 Shimizu Pharmaceutical Co., Ltd. Bowel cleansing agent
DE10208335A1 (de) 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
DE10239161A1 (de) 2002-08-27 2004-03-11 Ludwig Kraemer Verwendung einer Vitamin C und Magnesium entahltenden Zusammensetzung zur Anregung der Darmtätigkeit
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
CN1708270A (zh) 2002-10-29 2005-12-14 转化医药公司 丙泊酚与半胱氨酸
JP2004323479A (ja) 2003-04-28 2004-11-18 Ajinomoto Co Inc 便秘用緩下剤
JP2004323456A (ja) 2003-04-28 2004-11-18 Shimizu Pharmaceutical Co Ltd 腸管洗浄製剤
EP1663257B1 (en) 2003-07-09 2009-01-07 Braintree Laboratories, Inc. Use of laxatives for treating irritable bowel syndrome
WO2005049049A1 (en) 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
US20050226906A1 (en) 2004-04-08 2005-10-13 Micro Nutrient, Llc Nutrient system for individualized responsive dosing regimens
GB0409104D0 (en) 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
AU2004320512A1 (en) 2004-06-04 2005-12-22 Braintree Laboratories, Inc. Method of bowel cleansing
GB0507167D0 (en) 2005-04-08 2005-05-18 Glaxosmithkline Consumer Healt Composition
WO2006122104A1 (en) 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
WO2007037803A2 (en) 2005-09-16 2007-04-05 Eli Ehrenpreis Water-soluble colonoscopy lubricant
US20070082061A1 (en) * 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
CN1813674A (zh) 2005-12-12 2006-08-09 王冕 一种用于静脉给药的维生素c钠制剂及其制备方法
CN100476462C (zh) 2006-06-20 2009-04-08 刘彤 反射镜基体及其制造方法
CN101795681B (zh) 2007-08-31 2013-06-05 辉力公司 预防肾钙质沉着的方法
US20100297264A1 (en) 2007-10-17 2010-11-25 Thomas Jefferson University Bowel purgative and uses thereof
DE102007052870A1 (de) 2007-11-02 2009-05-07 Sasol Germany Gmbh Verwendung von Polyethylenglykol-Pulvern und Zusammensetzungen enthaltend diese
CN101450074B (zh) 2007-11-30 2012-03-14 凌沛学 一种明显改善胃肠道功能、防治便秘的组合物
CN101496589A (zh) 2008-01-29 2009-08-05 北京康必得药业有限公司 膳食纤维咀嚼片剂
US20090232943A1 (en) 2008-03-12 2009-09-17 Aly Gamay Stabilized vitamin solutions; use thereof; process for their production; and formulations comprising the same
US20090258090A1 (en) 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
SI2294012T1 (sl) * 2008-05-07 2014-11-28 Salix Pharmaceuticals, Ltd. Dajanje ÄŤistila za ÄŤrevo in antibiotika za zdravljenje ÄŤrevesne bolezni
CN101766563A (zh) 2008-12-29 2010-07-07 山东北大高科华泰制药有限公司 一种水溶性维生素注射剂与氯化钠注射液的配合使用方法
US20100178360A1 (en) 2009-01-13 2010-07-15 Universite Libre De Bruxelles Nutritive composition
US20100255122A1 (en) * 2009-04-02 2010-10-07 Garren Mary L Edible gelatin bowel preparation and bowel cleansing method
LT2421373T (lt) 2009-04-21 2020-01-10 Dale R. Bachwich Gaubtinės žarnos lavažo sistema
CA2765033C (en) * 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
AU2011101324B4 (en) 2009-07-17 2012-01-19 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0912487D0 (en) * 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
SI2322190T1 (sl) * 2009-11-02 2013-08-30 Promefarm S.R.L. Sestavki za izpiranje äśrevesja in uporaba le-teh
CN101766648B (zh) 2010-03-02 2012-01-11 舒泰神（北京）生物制药股份有限公司 聚乙二醇电解质颗粒制剂及其制造方法
BR112012022775A2 (pt) 2010-03-10 2016-07-19 Nogra Pharma Ltd composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas
GB201018650D0 (en) 2010-11-04 2010-12-22 Norgine Bv Methods and compositions
AU2011324995B2 (en) 2010-11-04 2015-12-24 Norgine Bv Formulations comprising polyethylene glycol
DE202010016398U1 (de) 2010-12-09 2011-04-28 Norgine B.V. Verbesserungen bei pharmazeutischen Zusammensetzungen und bezüglich pharmazeutischer Zusammensetzungen
CN103391790B (zh) 2011-01-28 2016-06-15 布伦特里实验室有限公司 用于肠道清洁的方法、组合物以及包装
KR101935769B1 (ko) 2011-01-31 2019-01-08 이에이 파마 가부시키가이샤 복실 용기
EA028925B1 (ru) 2011-01-31 2018-01-31 Норджин Бв Способ лечения констипации и/или уплотнения фекальных масс, водный раствор для лечения констипации и/или уплотнения фекальных масс, набор и лекарственное средство (варианты)
GB201103942D0 (en) 2011-03-08 2011-04-20 Norgine Bv Compositions
TWI535461B (zh) * 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
JP5708141B2 (ja) 2011-03-30 2015-04-30 味の素株式会社 経口投与用液剤を調製するための経口投与用製剤
WO2013001315A1 (en) 2011-06-30 2013-01-03 Zernicka-Goetz Magdalena Dorota Materials and methods for cell culture
CN106526186A (zh) 2011-09-12 2017-03-22 克里蒂科斯有限责任公司 检测靶分子的非侵入性方法
US20130102661A1 (en) 2011-10-25 2013-04-25 The Chinese University Of Hong Kong Irrigation solutions containing ascorbic acid or its salts and use thereof
JP6240610B2 (ja) 2011-10-27 2017-11-29 サリックス ファーマシューティカルズ，インコーポレイテッド 電解質下剤
US9149493B2 (en) 2011-11-28 2015-10-06 Alfa Wassermann Spa Compositions for bowel cleansing and use thereof
PT2787982T (pt) 2011-12-07 2023-05-10 Msm Innovations Inc Composição para preparação intestinal
CA2799881A1 (en) 2011-12-20 2013-06-20 Water Pik, Inc. Nasal wash solution
CN102600201B (zh) 2012-02-07 2014-07-16 舒泰神（北京）生物制药股份有限公司 用于通便和清肠的药物组合物及其制备方法
KR101210831B1 (ko) 2012-02-10 2012-12-11 주식회사태준제약 폴리에틸렌글리콜과 비타민 씨를 함유하는 장관 하제 조성물
CN102805752B (zh) 2012-08-20 2014-04-02 深圳万和制药有限公司 复方聚乙二醇电解质散及其制备方法
CN102805753B (zh) 2012-08-20 2014-09-24 深圳万和制药有限公司 包含聚乙二醇和电解质的药物组合物
CN102772427B (zh) 2012-08-20 2014-02-05 深圳万和制药有限公司 一种复方聚乙二醇电解质组合物
KR20210063445A (ko) * 2012-09-11 2021-06-01 노어긴 비.브이. Peg 및 아스코르베이트를 포함하는 조성물
CN103550212A (zh) 2013-11-03 2014-02-05 王显著 含匹可硫酸和抗坏血酸的药物组合物
CN103550249B (zh) 2013-11-09 2015-08-12 王显著 一种用于肠道准备的药物组合物
JP6295194B2 (ja) 2014-12-22 2018-03-14 エルジー ディスプレイ カンパニー リミテッド 電子部品の実装方法

Also Published As

Publication number Publication date
IL237377A0 (en) 2015-04-30
AU2013314442A1 (en) 2015-03-26
NL2011424C2 (en) 2015-03-12
PL2895163T3 (pl) 2019-10-31
SG10201807427RA (en) 2018-09-27
NZ705499A (en) 2018-07-27
AU2013314442C1 (en) 2018-10-11
US10918723B2 (en) 2021-02-16
CA3116204A1 (en) 2014-03-20
HUE043605T2 (hu) 2019-08-28
HRP20191007T1 (hr) 2019-08-23
IL269024A (en) 2019-10-31
CN106102738A (zh) 2016-11-09
JP2017507965A (ja) 2017-03-23
ZA201501415B (en) 2017-09-27
US20180311361A1 (en) 2018-11-01
SI2895163T1 (sl) 2019-07-31
IL237377B (en) 2019-09-26
JP2020073579A (ja) 2020-05-14
ES2909386T3 (es) 2022-05-06
MY193378A (en) 2022-10-07
NZ743984A (en) 2019-10-25
WO2014040994A1 (en) 2014-03-20
US20140228432A1 (en) 2014-08-14
SG10201702005VA (en) 2017-04-27
BR112015005270A8 (pt) 2019-08-13
US12083179B2 (en) 2024-09-10
US20170258919A1 (en) 2017-09-14
AR092500A1 (es) 2015-04-22
US8999313B2 (en) 2015-04-07
CA3116204C (en) 2023-09-12
PT3473248T (pt) 2022-03-30
SG10202112138QA (en) 2021-12-30
ZA201603747B (en) 2022-09-28
RS58979B1 (sr) 2019-08-30
MX2016011256A (es) 2016-11-15
CN105007915A (zh) 2015-10-28
EA028866B1 (ru) 2018-01-31
TW202017562A (zh) 2020-05-16
JP7277396B2 (ja) 2023-05-18
KR20230010844A (ko) 2023-01-19
US20210346503A1 (en) 2021-11-11
LT2895163T (lt) 2019-06-25
US20160235854A1 (en) 2016-08-18
SG11201501713XA (en) 2015-04-29
BR112015005270A2 (pt) 2017-07-04
JP6557675B2 (ja) 2019-08-07
JP6655391B2 (ja) 2020-02-26
MX359318B (es) 2018-09-25
EP2895163A1 (en) 2015-07-22
CA2884472A1 (en) 2014-03-20
ES2728459T3 (es) 2019-10-24
US20140186470A1 (en) 2014-07-03
BR112015005270B1 (pt) 2022-11-01
EA201500320A1 (ru) 2015-06-30
KR20150054990A (ko) 2015-05-20
DK3473248T3 (da) 2022-04-04
MY174758A (en) 2020-05-13
CN105007915B (zh) 2018-09-28
AU2013314442B2 (en) 2018-04-19
AU2018204694C1 (en) 2020-04-09
EP2895163B1 (en) 2019-03-06
AU2018204694B2 (en) 2019-09-26
ES2831412T3 (es) 2021-06-08
EP3473248A1 (en) 2019-04-24
EP3473248B1 (en) 2022-01-05
KR20190137925A (ko) 2019-12-11
US9326969B2 (en) 2016-05-03
HK1206604A1 (en) 2016-01-15
MX2015003031A (es) 2015-06-10
US9707297B2 (en) 2017-07-18
ME03413B (me) 2020-01-20
KR20170098980A (ko) 2017-08-30
US10016504B2 (en) 2018-07-10
KR20210063445A (ko) 2021-06-01
US20150182501A1 (en) 2015-07-02
US20160184263A1 (en) 2016-06-30
KR101771586B1 (ko) 2017-08-25
US20170173156A1 (en) 2017-06-22
PL3473248T3 (pl) 2022-07-25
CA2884472C (en) 2021-06-22
UA116546C2 (uk) 2018-04-10
KR102257207B1 (ko) 2021-05-31
TWI687238B (zh) 2020-03-11
DK2895163T3 (da) 2019-06-03
JP2015527385A (ja) 2015-09-17
TW201416092A (zh) 2014-05-01
IN2015DN01704A (el) 2015-05-22
AU2018204694A1 (en) 2018-07-19
PT2895163T (pt) 2019-06-14
TWI756623B (zh) 2022-03-01

Similar Documents

Publication Publication Date Title
CY1121668T1 (el) Συνθεσεις οι οποιες περιλαμβανουν peg και ασκορβικο
CY1123779T1 (el) Κολονοσκοπηση-προετοιμασια
CY1121225T1 (el) Συμπυκνωμενες iμιδαζολυλιμιδαζολες ως αντιiκες ενωσεις
CY1120651T1 (el) Παραγωγα λακταμης χρησιμα ως αναστολεις μεταλλαγμενης idh1
CY1120480T1 (el) Ενωσεις πυραζολοπυριμιδινης
CY1123689T1 (el) Κρυσταλλικη μορφη ελευθερης βασης λορλατινιβης
CY1119605T1 (el) Παραγωγα 5-αρυλο ή 5-ετεροαρυλο υποκατεστημενου 3-υδροξυπυριδιν-2-υλ-καρβονυλαμινο-αλκανοϊκου οξεος και αλατα αυτων καθως και παρασκευη τους απο τα αντιστοιχα παραγωγα 3-υδροξυ-πικολινικου οξεος
UA113643C2 (xx) N-цикліламіди як нематоциди
CR20140525A (es) Compuestos de N-alquiltriazol como antagonistas de LPAR
ECSP14013245A (es) Nuevos derivados dihidroquinolina-2-ona
CY1123134T1 (el) Φαρμακευτικο σκευασμα που περιεχει ινοσιτολη
UY33665A (es) Derivado peptídico
EA201490846A1 (ru) Новые производные арилхинолина
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
UY34442A (es) 2-tiopirimidinonas.
NI201300034A (es) Conjugado de naloxol - peg cristalino
CY1117912T1 (el) Ενωσεις πυραζολιου ως αναστολεiς του συμμεταφορεα νατριου-γλυκοζης 1 (sglt1)
EA201692341A1 (ru) Соли дазатиниба
CY1121484T1 (el) Μορφες αλατος και κρυσταλλου ενος αναστολεα plk-4
CY1116142T1 (el) Εισπνεομενο φαρμακο που περιλαμβανει τιοτροπιο
EA201590041A1 (ru) Твердая форма холиновой соли вемурафениба
EA201400058A1 (ru) Соединения и композиции на основе амидопиридиловых эфиров и их применение против паразитов
UY34553A (es) Procedimiento de preparación de la sal de l-arginina de perindoprilo
CY1120101T1 (el) Παραγωγο πυριδονης και φαρμακο που το περιεχει
UY33975A (es) Formulaciones de otamixaban con estabilidad mejorada